Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Myelin Disorders Biorepository Project and Global Leukodystrophy Initiative Clinical Trials Network

NCT03047369 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03047369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Myelin Disorders Biorepository Project and Global Leukodystrophy Initiative Clinical Trials Network
Lead sponsor
Children's Hospital of Philadelphia
Phase
Observational
Overall status
Recruiting
Start date
December 8, 2016
Completion date
December 8, 2030
Enrollment
12,000 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

4h syndrome, adld, adrenoleukodystrophy, adrenomyeloneuropathy, ags, aicardi goutieres syndrome, ald, ald (adrenoleukodystrophy), ald gene mutation, alexander disease, alexanders leukodystrophy, allan-herndon-dudley syndrome, alsp, amn, axd, bpan, cadasil, canavan disease, cerebrotendinous xanthomatoses, charcot-marie-tooth, cmt, cockayne syndrome, csf1r gene mutation, ctx, galc deficiency, gangliosidoses, globoid leukodystrophy, gm2 gangliosidosis, h-abc - hypomyelination, atrophy of basal ganglia and cerebellum, hbsl, hbsl - hypomyelination, brain stem, spinal cord, leg spasticity, hcc - hypomyelination and congenital cataract, krabbe disease, labrune syndrome, lbsl, lcc, leukodystrophy, leukoencephalopathies, leukoencephalopathy with brain stem and spinal cord involvement and high lactate syndrome (disorder), leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation, mct8 (slc16a2)-specific thyroid hormone cell transporter deficiency, megalencephalic leukoencephalopathy with subcortical cysts, metachromatic leukodystrophy, mlc1, mld, mucopolysaccharidoses, multiple sulfatase deficiency, pelizaeus merzbacher like disease, pelizaeus-merzbacher disease, peroxisomal biogenesis disorder, plp1 gene duplication | blood or tissue | mutations, plp1 null syndrome, pmd, refsum disease, salla disease, sialic storage disease, sjogren-larsson syndrome, sjögren, tbck-related intellectual disability syndrome, tubb4a-related leukodystrophy, van der knapp disease, vanishing white matter disease, white matter disease, x-ald, x-linked adrenoleukodystrophy, zellweger syndrome